AR and neoplasm: In addition, transcriptional hijacking of AR is accompanied by extensive reprogramming of the AR cistrome, which displays increased AR binding sites, as well as enrichment of the pioneer factor FOXA1 and the homeobox factor HOXB13 at tumour-specific AR binding sites, further promoting oncogenic activation of AR [51].